The authors reported that one of their inhibitors blocked amitriptyline-induced vesicle damage in breast carcinoma MCF-7 cells, possibly by blocking the interaction between galectin-3 and LAMP1/2 proteins. This evidence concerns the gene LGALS3 and breast carcinoma.